For Immediate Release
Media Contact: Bob Cooper
Date: November 15, 2012
GlaxoSmithKline To Pay Idaho $1.33 Million for Deceptive Claims
(Boise) – Idaho will receive $1.33 million from a consent judgment reached between GlaxoSmithKline LLC and 37 other state Attorneys General, Attorney General Lawrence Wasden said. While admitting no wrongdoing, GlaxoSmithKline agreed to pay $90 million to resolve allegations that it unlawfully promoted its diabetes drug, Avandia.
The states allege that GlaxoSmithKline made claims that Avandia had cardiovascular benefits, which it did not. The drug may actually increase cardiovascular risks.
Under the consent judgment, GlaxoSmithKline may not:
Idaho's portion of the settlement will be deposited in the Consumer Protection Account, which is subject to legislative appropriation.
This is the third settlement the Attorney General's Consumer Protection Division has reached with GlaxoSmithKline.
- End -